NEWS & EVENTS Event Calendars Event

Time & Date

4:00-5:30 PM,Wednesday,April 7,2021

Venue

Room 312, 3F, Building 3,Yunqi Campus

Host

Prof. Duanqing Pei, Chair Professor, School of Life Sciences, Westlake University

Audience

Faculty and Staff,Graduate Students,Undergraduate Students

Category

Academics and Research

SLS Special Seminar | Kang Zhang:Translating big data, AI and drug discovery into better healthcare delivery and therapies

Time4:00-5:30 PM,Wednesday,April 7,2021

Venue: Room 312, 3F, Building 3,Yunqi Campus

HostProf. Duanqing Pei, Chair Professor, School of Life Sciences, Westlake University


Speaker:

Prof. Kang Zhang

Macau University of Science and Technology (MUST)


Dr. Zhang obtained his M.D. with Magna Cum Laude honors from Harvard Medical School and MIT joint MD program and his PhD in genetics from Harvard University. He did his postdoctoral training also at Harvard.  He completed his residency in ophthalmology at Johns Hopkins University and his retina surgery fellowship at University of Utah. He was a faculty member at Johns Hopkins University, Cleveland Clinic Foundation, University of Utah, and University of California San Diego. 

Among his honors include AAAS fellow, fellow of American Institute for Medical and Biological Engineering, memberships in Association of American Physicians and American Society of Clinical Investigation; Outstanding Achievement Award of Chinese Ophthalmological Society, Burroughs Wellcome Clinical Scientist Award in Translational Research; Lew R. Wasserman Merit Award and Senior Investigator Award from Research to PreventBlindness; Charles Schepens Award for Excellence in Retina Research; and Johns Hopkins Medical Institutions Clinician Scientist Award, the Ophthalmologist 100 Powerlist, American’s Top Ophthalmologists.


Abstract:

Dr. Zhang is renowned for his cutting-edge translational research and their commercial applications. He has pioneered using artificial intelligence to diagnose diseases and improve treatments based on medical big data, such as the AI fundus diagnostic system and AI-assisted diagnostic system for COVID-19 pneumonia based on chest CT images. The AI-assisted diagnostic system for COVID-19 can effectively distinguish COVID-19 from other viral pneumonia and predict the severity level within 20 seconds, with an accuracy of more than 90%, which is equivalent to the diagnostic level of an associate professor of imaging in a provincial third-grade hospital. It has been deployed around the world to fight against the pandemic globally. He identified many important novel genes and therapies for blindness including macular degeneration, cataract, glaucoma and myopia, which affect billions of people world-wide. For the drug discovery, he has developed an innovative eye drug which is a new tyrosine kinase receptor inhibitor for the treatment of macular degeneration, diabetic retinopathy, corneal neovascularization and other common blinding diseases. Additionally, Dr. Zhang has identified an aging epigenetic clock and designed methods to reverse it. He has pioneered methods of noninvasive diagnosis of common solid cancers and fetal chromosomal aneuploidies using cell-free DNA from blood samples (so called liquid biopsy).  


Contact:

生命科学学院

于文越 yuwenyue@westlake.edu.cn



Time & Date

4:00-5:30 PM,Wednesday,April 7,2021

Venue

Room 312, 3F, Building 3,Yunqi Campus

Host

Prof. Duanqing Pei, Chair Professor, School of Life Sciences, Westlake University

Audience

Faculty and Staff,Graduate Students,Undergraduate Students

Category

Academics and Research